Purpose: We conducted a study to determine which factors may be useful as predictive markers in identifying Kawasaki disease (KD) patients with a high risk of resistance to intravenous immunoglobulin (IVIG) and developing coronary artery lesions (CAL). Methods: We enrolled 287 patients in acute phase of KD at a single center. The demographic, clinical and laboratory data were collected retrospectively. Results: There were 34 patients in the IVIG resistant group. The IVIG resistant group had signifi cantly higher serum N-terminal-pro-brain natriuretic protein (NT-proBNP) levels (P<0.01) and polymorphonuclear neutrophil (PMN) percentage (P<0.01) in comparison to the IVIG responders. The results yielded sensitivity (78.8%, 60.6%), specificity (58.2%, 90%) and cutoff value (628.6 pg/mL, 80.3%) of NT-proBNP and PMN respectively, in predicting IVIG resistance. Despite IVIG administration, 13 of the 287 patients developed CAL. The patients in the CAL group had higher NT-proBNP levels (P<0.01) and higher PMN percentage (P<0.01). In these patients, the results yielded sensitivity (73.3%, 56.7%), specificity (67.9%, 88.9%) and cutoff value (853.4 pg/mL, 80.3%) of NT-proBNP and PMN respectively, for predicting CAL. The area under the curve (AUC) for predicting resistance to IVIG was NT-proBNP 0.712, PMN 0.802. The AUC for predicting CAL was NT-proBNP 0.739, and PMN 0.773. Conclusion: Serum NT-proBNP levels and PMN percentage were significantly elevated in patients with KD with IVIG resistance and CAL. Thus, they may be useful predicting markers for IVIG resistance and development of CAL in KD patients.
Introduction
Kawasaki disease (KD) is an acute febrile illness of childhood, a vasculitis of unknown etiology 1) , and is the most common cause of acquired cardiac disorders in pediatric patients 2) . There are no specific diagnostic laboratory markers for KD 3) . Coronary artery complications develop in 20% to 25% of untreated KD patients 4) . Early detection and treatment reduce the incidence of serious coronary artery complications.
Recent studies have investigated factors for predicting resistance to intravenous immunoglobulin (IVIG) as well as coronary artery lesions (CALs) in patients with KD, but the results have been conflicting.
The purpose of our study was to determine which factors can be useful as predictive markers for patients with KD who are at higher risk of IVIG resistance and developing CAL.
Materials and methods
KD was diagnosed according to the criteria published by the American Heart Association (AHA) in 2004. Diagnosis of in complete KD was based on the diagnostic criteria established by AHA 2) . All patients received 50 mg/kg/day acetylsalicylic acid until they were afebrile and 2 g/kg of IVIG over 12 hours. The onset of KD including incomplete (atypical) KD was defined as the day of fever onset.
We conducted a retrospective review of medical records for 287 KD patients, admitted to Inje University Haeundae Paik Hospital between September 2010 and December 2015.
IVIG resistance was defined as persistent or recrudescent fever (temperature>38.0°C) after more than 36 hours following com pletion of IVIG infusion (2 g/kg). CALs were assessed by perform ing serial echocardiography, primarily by quantifying the internal coronary artery dimension as per the Japanese Ministry of Health criteria: a maximum absolute internal diameter >3 mm in child ren <5 years of age, or >4 mm in children 5 years and older, or segment 1.5 times greater than an adjacent segment, or the pre sence of luminal irregularity. We also diagnosed the presence of CAL whenever body surface areaadjusted Z score of any coro nary artery was ≥+2.5, including left main, left anterior descend ing, and right coronary arteries 2) . All laboratory data used in this study were obtained at admis sion before the initiation of IVIG therapy. The laboratory investi gations included white blood cell count, polymorphonuclear neu trophil (PMN) percentage, albumin, total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), Creac tive protein (CRP), Nterminalprobrain natriuretic protein (NT proBNP).
Statistical analysis was performed using IBM SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). A univariate analysis was performed on the clinical data of the KD patients in the IVIG re sistant and CAL groups, in which categorical data were present ed as as either significantly different or correlated. To assess the ability of laboratory factors for percentages and were analyz ed using the Student t test. Quantitative data with normal distribu tion were presented as mean±standard deviation. A P<0.01 was considered predicting IVIG resistance and CAL development, the diagnostic performances of the parameters con sidered were investigated by receiver operating characteristic (ROC) analysis. This technique summarized the validity coeffi cients of a para meter and an overall index of diagnostic accuracy, the area under the curve (AUC) from a plot. Based on ROC analysis, the best statistical cutoff value for each parameter (the point at which the sum of falsepositives and falsenegatives is less than any other point) was calculated.
Results
Two hundred eightyseven children (159 male and 128 female), age range: 2 months to 13 years 3 months (median age, 2.2 years), presenting with acute phase of KD were enrolled in this study. Patients with typical KD and incomplete KD accounted for 88.2% (n=253) and 11.8% (n=34), respectively. The number of patients who developed CAL was significantly higher in the IVIG resistant group, 65% (21 of 34) in IVIG resis tant group vs. 0.04% (9 of 253) in IVIG responding group (P< 0.001). The laboratory data showed significant differences between the IVIG responding group and the IVIG resistant group (Table 1) . Compared to the IVIG responding group, the IVIG resistant group had higher NTproBNP levels (2,255.02±3,150.97 pg/mL vs. 1,127.10±2,033.60 pg/mL, P<0.01), higher serum CRP levels (10.46±5.28 mg/dL vs. 7.82±6.00 mg/dL, P=0.015), higher The NTproBNP cutoff value of 628.6 pg/mL yielded a sensi tivity of 78.8%, a specificity of 58.2% for predicting IVIG resistant group in the acute phase of KD. The CRP cutoff value of 6.81 mg/ dL yielded a sensitivity of 81.8% and a specificity of 54.2% for predicting IVIG resistance. The PMN cutoff value of 80.3% yield ed a sensitivity of 60.6% and a specificity of 90% for predicting IVIG resistance.
The NTproBNP levels significant for predicting IVIG resistance in KD patients were assessed by a ROC curves analysis (Fig. 1) . The AUC for predicting resistance to IVIG ( (Table 3 ). An NTproBNP cutoff value of 853.4 pg/mL yielded a sensi tivity of 73.3%, a specificity of 67.9% for predicting CAL in the tors that could predict which patients will require further therapy for refractory disease. The presence of one or more of these risk factors for treatment failure should alert clinicians to an increased likelihood that the patient may not respond adequately to the initial IVIG therapy. The ability to predict a lack of response to IVIG before initiating therapy, would allow clinicians to identify these patients because they might benefit from more aggressive treatment. Several previous studies reported increased patient serum NT proBNP levels in acute phase of KD, thus providing useful mar kers for diagnosing KD 510) . In addition, several studies have published data that NTproBNP could be used for predicting re sistance to IVIG therapy and patients who are at high risk for CAL 1113) . The NTproBNP is a prohormone with a 76 amino acid Nter minal inactive protein that is cleaved from the molecule to release brain natriuretic peptide (BNP). BNP is a diuretic peptide that is secreted mainly from cardiac ventricles. BNP and NTproBNP has been correlated with echocardiographic measure ments as a sug gestive marker for diastolic dysfunction 14, 15) . The mechanisms by which the elevated levels of serum NT proBNP occur in the acute phase of KD are not clear at the present time, however there is a possibility that proinflammatory cyto kines such as tumor necrosis factorα or interleukin1 beta, known to be increased in the acute phase of KD, induce the secre tion of BNP from myocytes 16) . A linear correlation between NT proBNP and CRP levels was present in the current study ([NT proBNP=0.147 CRP+103.936]; P<0.01) (Fig. 3). acute phase of KD. The CRP cutoff value of 9.4 mg/dL yielded a sensitivity of 63.3% and a specificity of 71.6% for predicting CAL. The PMN percentage cutoff value of 80.3% yielded a sensitivity of 56.7% and a specificity of 88.9% for predicting CAL.
The NTproBNP level for predicting CAL in patients with KD was assessed by an ROC curves analysis (Fig. 2) . The AUC for predicting CAL with various variables were as follows: PMN percentage, 0.773; serum NTproBNP, 0.739; CRP, 0.676; total bilirubin, 0.698; ALT, 0.621; serum albumin, 0.322 (Table 2) .
Discussion
The diagnostic criteria of KD were set forth over 40 years ago. Despite several revisions over the years, they are still insufficient for adequate diagnosis of the disease. Unfortunately, there are no diagnostic tests currently available that help early diagnosis of KD patients. Our results suggest that the serum NTproBNP levels and PMN percentage are significantly elevated in patients with KD with IVIG resistance and CAL and may be useful predicting markers.
Some patients with KD fail initial IVIG therapy for reasons that are not clear. Retrospective studies have identified potential fac The serum concentration of NTproBNP may be useful for predicting IVIG resistance and CAL in patients with the acute phase of KD. It is worthwhile to consider and evaluate risk stra tified strategies for patients at a higher risk of developing severe KD, based on the serum concentration of NTproBNP.
Kaneko K et al. 11) previously reported that NTproBNP can be a useful biomarker to predict which patients with KD are at greater risk of CAL before initial IVIG. And in another study by Yoshi mura et al. 12) , they further confirmed that the serum NTproBNP levels increased in KD children with CAL in a larger sample and also found that it was increased in IVIG nonresponders. In that study, 19 of the 80 patients developed CAL, despite IVIG admini stration. They had significantly higher serum NTproBNP levels in comparison with the patients without CAL. The NTproBNP cutoff value of 1,300 pg/mL yielded a sensitivity of 95% and a specificity of 85% for predicting CAL. However, 17 of the 80 patients were IVIG nonresponders. They also had significantly higher serum NTproBNP levels in comparison with the IVIG responders. The NTproBNP cutoff value of 800 pg/mL yielded a sensitivity of 71% and a specificity of 62% for predicting IVIG nonresponders. Kim et al. 13) also showed that NTproBNP is a helpful marker in determining patients at risk for not responding to initial IVIG treatment. By using larger data in our study, we further confirmed that the serum NTproBNP levels are also increased in children with KD, having CAL and IVIG resistance.
By the AUC, the serum levels of PMN percentage, NTproBNP, and CRP were considered to be good predictors for IVIG resis tance in KD patients. The serum levels of NTproBNP and PMN percentage were considered to be good predictors for developing CAL in KD patients. These results were compared to previous study. In that study, the serum level of NTproBNP and serum CRP were considered to be better single predictor for IVIG non responders. And the serum level of NTproBNP was considered to be the best single predictor for CAL among these biochemical markers in patients with KD 12) . Moreover, our study also revealed significantly higher levels of total bilirubin and ALT. However serum albumin levels were significantly lower in both IVIG resistant and CAL groups (Tables  1, 3) . These values correlated with the results of our previous metaanalysis study of laboratory predictive factors for IVIG resistant KD. Metaanalysis of twelve studies, comprising 2,745 patients, demonstrated that laboratory predictive factors for IVIG resistant KD included higher levels of total bilirubin, PMN per centage, NTproBNP, ALT, CRP, and lower sodium and albumin 17) . In our study, PMN percentage was an important laboratory predictive factor in addition to NTproBNP. Our results correlated with the findings of Ha et al. 18) . In their study in patients with acute febrile phase of KD, IVIG resistant patients had higher neu trophiltolymphocyte ratios (NLR) than IVIG responsive patients.
They also observed higher NLR in patients with aneu rysms, but not in patients with dilatation, compared to that in patients without coronary artery abnormalities. Their study con cluded that an NLR>1 two days after IVIG was predictive of coronary aneurysm development and IVIG resistance.
While controversy remains as to which risk factors predict patient resistance to IVIG, and treatment regimens to reduce the risk of developing CAL, the presence of several predictive factors in our study, especially proBNP and PMN percentage, should alert clinicians to the increased probability of the patient not respond ing adequately to initial IVIG therapy and developing CAL.
In conclusion, the serum NTproBNP, PMN percentages, CRP and total bilirubin are increased significantly in KD patients with IVIG resistance and CAL. Serum NTproBNP levels and PMN percentage may be useful for predicting IVIG resistance and CAL in KD.
